25.31
전일 마감가:
$24.41
열려 있는:
$23.19
하루 거래량:
1.22M
Relative Volume:
0.95
시가총액:
$3.23B
수익:
$8.40M
순이익/손실:
$-237.42M
주가수익비율:
-13.17
EPS:
-1.9213
순현금흐름:
$-377.03M
1주 성능:
-8.30%
1개월 성능:
-7.22%
6개월 성능:
-4.63%
1년 성능:
+476.54%
Alumis Inc Stock (ALMS) Company Profile
명칭
Alumis Inc
전화
650-231-6625
주소
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Compare ALMS vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ALMS
Alumis Inc
|
25.31 | 3.26B | 8.40M | -237.42M | -377.03M | -1.9213 |
|
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
|
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-11 | 개시 | Raymond James | Strong Buy |
| 2026-02-25 | 개시 | Stifel | Buy |
| 2026-01-21 | 개시 | Chardan Capital Markets | Buy |
| 2025-07-25 | 개시 | Wells Fargo | Overweight |
| 2025-06-10 | 재개 | Guggenheim | Buy |
| 2025-01-30 | 개시 | Oppenheimer | Outperform |
| 2024-10-31 | 개시 | Robert W. Baird | Outperform |
| 2024-10-17 | 개시 | H.C. Wainwright | Buy |
| 2024-07-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-23 | 개시 | Guggenheim | Buy |
| 2024-07-23 | 개시 | Leerink Partners | Outperform |
| 2024-07-23 | 개시 | Morgan Stanley | Overweight |
모두보기
Alumis Inc 주식(ALMS)의 최신 뉴스
Alumis (NASDAQ:ALMS) Lowered to "Strong Sell" Rating by Wall Street Zen - marketbeat.com
Alumis' (ALMS) "Neutral" Rating Reaffirmed at HC Wainwright - marketbeat.com
Alumis (NASDAQ:ALMS) Shares Gap Down After Earnings Miss - marketbeat.com
Alumis Swings to Q2 Net Loss, Revenue Falls - marketscreener.com
ALMS SWOT Analysis: Financial Challenges and Opportunities Revea - GuruFocus
Alumis (NASDAQ:ALMS) Issues Earnings Results - marketbeat.com
Alumis Q2 Results: EPS Misses Estimate, Sales Fall 37% YoY - scanx.trade
Alumis (ALMS) Posts Q2 Loss; Price-to-Sales Ratio Highlights Mar - GuruFocus
Alumis Inc. (ALMS) reports $235M loss but ends quarter with $502M cash - Stock Titan
Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements - The Manila Times
Earnings Flash (ALMS) Alumis Inc. Reports Q2 Revenue $1.7M, vs. FactSet Est of $3.5M - marketscreener.com
Earnings Flash (ALMS) Alumis Inc. Reports Q2 Revenue $1.7M, Vs. FactSet Est of $3.5M - moomoo.com
California State Teachers Retirement System Raises Stock Position in Alumis Inc. $ALMS - marketbeat.com
Alumis (NASDAQ:ALMS) Trading Down 9.6%Should You Sell? - marketbeat.com
4 Psoriasis Drug Stocks to Watch During Psoriasis Awareness Month 2026 - The Globe and Mail
Alumis Psoriasis Treatment Shows Leading Skin Clearance Rates - Benzinga
Alumis reports 54% complete skin clearance in psoriasis trial By Investing.com - Investing.com South Africa
Alumis reports 54% complete skin clearance in psoriasis trial - Investing.com
Alumis: Envudeucitinib Shows 54% PASI 100 at 48 Weeks, NDA on Track for 4Q 2026 - TradingView
First Trust Advisors LP Takes $1.46 Million Position in Alumis Inc. $ALMS - marketbeat.com
Alumis Inc (ALMS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alumis Inc. $ALMS Shares Bought by The Manufacturers Life Insurance Company - marketbeat.com
Technical Reactions to ALMS Trends in Macro Strategies - Stock Traders Daily
FMR reports 5.5% stake in Alumis Inc | ALMS SEC FilingForm SCHEDULE 13G - Stock Titan
Bank of New York Mellon Corp Raises Holdings in Alumis Inc. $ALMS - MarketBeat
Alumis (NASDAQ:ALMS) Insider Jorn Drappa Sells 2,447 Shares of Stock - MarketBeat
Alumis (NASDAQ:ALMS) Insider Sanam Pangali Sells 1,364 Shares of Stock - MarketBeat
Alumis (NASDAQ:ALMS) CFO John Schroer Sells 3,282 Shares - MarketBeat
Alumis (ALMS) CFO sells 3,282 shares in tax-related sell-to-cover trade - Stock Titan
Alumis Inc. (ALMS) officer sells 2,692 shares in tax sell-to-cover trade - Stock Titan
Alumis Inc. (ALMS) CDO sells 2,572 shares to cover RSU taxes - stocktitan.net
Alumis (ALMS) to Post Quarterly Earnings on Wednesday - MarketBeat
Alumis (NASDAQ:ALMS) Given Neutral Rating at HC Wainwright - MarketBeat
Janus Henderson Group PLC Takes $46.79 Million Position in Alumis Inc. $ALMS - marketbeat.com
Swiss National Bank Takes $2.81 Million Position in Alumis Inc. $ALMS - marketbeat.com
Stempoint Capital LP Buys New Stake in Alumis Inc. $ALMS - marketbeat.com
166,959 Shares in Alumis Inc. $ALMS Purchased by Ally Bridge Group NY LLC - marketbeat.com
Elmind Capital LP Purchases New Shares in Alumis Inc. $ALMS - marketbeat.com
BlackRock, Inc. (ALMS) reports 7.1M-share, 5.7% beneficial stake in Alumis - Stock Titan
Alumis Market Sentiment - Benzinga España
ALMS|Alumis Inc|Price:27.070|Chg%:-0.930 - TradingKey
Orbimed Advisors LLC Has $12.08 Million Stock Holdings in Alumis Inc. $ALMS - marketbeat.com
ALMS|Alumis Inc|Price:26.312|Chg%:-0.768 - TradingKey
Alumis Inc (ALMS) Income Statement - tradingkey.com
Alumis Inc (ALMS) Balance Sheet - TradingKey
Alumis Inc (ALMS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alumis Inc (ALMS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Weiss Asset Management LP Buys New Shares in Alumis Inc. $ALMS - marketbeat.com
Alumis Inc (ALMS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ALMS|Alumis Inc|Price:28.000|Chg%:-0.300 - TradingKey
Alumis Inc. Revenue Breakdown – NASDAQ:ALMS - TradingView
Alumis Inc (ALMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):